CX3CR1 deficiency in three different AD mouse models reduces β-amyloid deposition, enhancing Aβ phagocytic ability by microglia (Lee et al., 2010; Liu et al., 2010b). This evidence concerns the gene CX3CR1 and Alzheimer disease.